Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Plasma cell 1NET 1Endocrine 1

Conditions

Neuroendocrine Tumors 1Neoplasms 1Multiple Myeloma 1Gastrointestinal Neoplasms 1

Interventions

Cisplatin 3trametinib 1repotrectinib 1pralsetinib 1lutetium Lu 177 dotatate 1lanreotide 1dabrafenib 1copper dotatate CU-64 1alectinib 1Surveys and Questionnaires 1Referral and Consultation 1Quality of Life 1Poly(ADP-ribose) Polymerase Inhibitors 1Nivolumab 1Neoadjuvant Therapy 1Microscopy, Electron 1Lutetium-177 1Lutetium 1Irinotecan 1Ipilimumab 1Etoposide 1Cytoreduction Surgical Procedures 1Cryotherapy 1Carboplatin 1CYT-6091 1Aromatherapy 1Acupuncture Therapy 1Acupressure 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Referral and Consultation × Endocrine × Clear all
NCT06908629 2025-08-26

Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

Barbara Ann Karmanos Cancer Institute

Phase NA Recruiting
120 enrolled
EndocrineGastrointestinalNETPlasma cell

Gastrointestinal Neoplasms, Multiple Myeloma, Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡